{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:14:13Z","timestamp":1761822853208},"reference-count":18,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Correlates between immunological parameters and protection against\n            <jats:italic>Bacillus anthracis<\/jats:italic>\n            infection in animals vaccinated with protective antigen (PA)-based vaccines could provide surrogate markers to evaluate the putative protective efficiency of immunization in humans. In previous studies we demonstrated that neutralizing antibody levels serve as correlates for protection in guinea pigs (S. Reuveny et al., Infect. Immun. 69:2888-2893, 2001; H.\u2009Marcus et al., Infect. Immun. 72:3471-3477, 2004). In this study we evaluated similar correlates for protection by active and passive immunization of New Zealand White rabbits. Full immunization and partial immunization were achieved by single and multiple injections of standard and diluted doses of a PA-based vaccine. Passive immunization was carried out by injection of immune sera from rabbits vaccinated with PA-based vaccine prior to challenge with\n            <jats:italic>B. anthracis<\/jats:italic>\n            spores. Immunized rabbits were challenged by intranasal spore instillation with one of two virulent strains (strains Vollum and ATCC 6605). The immune competence was estimated by measuring the level of total anti-PA antibodies, the neutralizing antibody titers, and the conferred protective immunity. The results indicate that total anti-PA antibody titers greater than 1\u2009\u00d7 10\n            <jats:sup>5<\/jats:sup>\n            conferred protection, whereas lower titers (between 10\n            <jats:sup>4<\/jats:sup>\n            and 10\n            <jats:sup>5<\/jats:sup>\n            ) provided partial protection but failed to predict protection. Neutralizing antibody titers between 500 and 800 provided partial protection, while titers higher than 1,000 conferred protection. In conclusion, this study emphasizes that regardless of the immunization regimen or the time of challenge, neutralizing antibody titers are better predictors of protection than total anti-PA titers.\n          <\/jats:p>","DOI":"10.1128\/iai.74.1.394-398.2006","type":"journal-article","created":{"date-parts":[[2005,12,20]],"date-time":"2005-12-20T22:02:58Z","timestamp":1135116178000},"page":"394-398","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":67,"title":["Immunological Correlates for Protection against Intranasal Challenge of\n            <i>Bacillus anthracis<\/i>\n            Spores Conferred by a Protective Antigen-Based Vaccine in Rabbits"],"prefix":"10.1128","volume":"74","author":[{"given":"Shay","family":"Weiss","sequence":"first","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kobiler","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Levy","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadar","family":"Marcus","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Pass","sequence":"additional","affiliation":[{"name":"Biotechnology, Israel Institute for Biological Research, Ness-Ziona, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nili","family":"Rothschild","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeev","family":"Altboum","sequence":"additional","affiliation":[{"name":"Departments of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6231-6241.2002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.19.111301.140655"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00021-4"},{"key":"e_1_3_2_5_2","first-page":"33","volume":"272","year":"2002","unstructured":"Friedlander, A., S. Welkos, and B. Ivins. 2002. Anthrax vaccines. Curr. Top. Microb. Immunol.272:33-60.","journal-title":"Curr. Top. Microb. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.2.544-550.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsle.2005.01.039"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.12.5171-5175.1997"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.07.004"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.52.2.509-512.1986"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.6.3471-3477.2004"},{"key":"e_1_3_2_12_2","first-page":"135","volume":"152","year":"2004","unstructured":"Mourez, M. 2004. Anthrax toxins. Rev. Physiol. Biochem. Pharmacol.152:135-164.","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.68.4.617-629.2004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00234-1"},{"key":"e_1_3_2_15_2","first-page":"213","volume":"19","year":"2001","unstructured":"Pittman, P., J. Mangiafico, C. Rossi, T. Cannon, P. Gibbs, G. Parker, and A. Friedlander. 2001. Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans. Vaccine19:213-216.","journal-title":"Vaccine"},{"key":"e_1_3_2_16_2","first-page":"493","volume":"27","year":"1938","unstructured":"Reed, L., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg.27:493-497.","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0882-4010(88)90015-0"},{"key":"e_1_3_2_19_2","first-page":"982","volume":"122","year":"1998","unstructured":"Zaucha, G., L. Pitt, J. Estep, B. Ivins, and A. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med.122:982-992.","journal-title":"Arch. Pathol. Lab. Med."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.74.1.394-398.2006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.74.1.394-398.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T06:16:30Z","timestamp":1646460990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.74.1.394-398.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1128\/IAI.74.1.394-398.2006"],"URL":"https:\/\/doi.org\/10.1128\/iai.74.1.394-398.2006","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"2005-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-10-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}